BMJ  2008;336:262-266 (2 February), doi:10.1136/bmj.39440.525752.BE (published 15 January 2008)

Research

Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial

Mark J Bolland, research fellow1, P Alan Barber, senior lecturer1, Robert N Doughty, associate professor1, Barbara Mason, research officer1, Anne Horne, research fellow1, Ruth Ames, research officer1, Gregory D Gamble, research fellow1, Andrew Grey, associate professor1, Ian R Reid, professor1

1 Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand

Correspondence to: I R Reid i.reid{at}auckland.ac.nz

Objective To determine the effect of calcium supplementation on myocardial infarction, stroke, and sudden death in healthy postmenopausal women.

Design Randomised, placebo controlled trial.

Setting Academic medical centre in an urban setting in New Zealand.

Participants 1471 postmenopausal women (mean age 74): 732 were randomised to calcium supplementation and 739 to placebo.

Main outcome measures Adverse cardiovascular events over five years: death, sudden death, myocardial infarction, angina, other chest pain, stroke, transient ischaemic attack, and a composite end point of myocardial infarction, stroke, or sudden death.

Results Myocardial infarction was more commonly reported in the calcium group than in the placebo group (45 events in 31 women v 19 events in 14 women, P=0.01). The composite end point of myocardial infarction, stroke, or sudden death was also more common in the calcium group (101 events in 69 women v 54 events in 42 women, P=0.008). After adjudication myocardial infarction remained more common in the calcium group (24 events in 21 women v 10 events in 10 women, relative risk 2.12, 95% confidence interval 1.01 to 4.47). For the composite end point 61 events were verified in 51 women in the calcium group and 36 events in 35 women in the placebo group (relative risk 1.47, 0.97 to 2.23). When unreported events were added from the national database of hospital admissions in New Zealand the relative risk of myocardial infarction was 1.49 (0.86 to 2.57) and that of the composite end point was 1.21 (0.84 to 1.74). The respective rate ratios were 1.67 (95% confidence intervals 0.98 to 2.87) and 1.43 (1.01 to 2.04); event rates: placebo 16.3/1000 person years, calcium 23.3/1000 person years. For stroke (including unreported events) the relative risk was 1.37 (0.83 to 2.28) and the rate ratio was 1.45 (0.88 to 2.49).

Conclusion Calcium supplementation in healthy postmenopausal women is associated with upward trends in cardiovascular event rates. This potentially detrimental effect should be balanced against the likely benefits of calcium on bone.

Trial registration Australian Clinical Trials Registry ACTRN 012605000242628.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Oral bisphosphonates and atrial fibrillation
Sumit R Majumdar
BMJ 2008 336: 784-785. [Extract] [Full Text] [PDF]

Results may not be generalisable
Joan M Lappe and Robert P Heaney
BMJ 2008 336: 403. [Extract] [Full Text] [PDF]

Confounders were ignored
Luca Puccetti
BMJ 2008 336: 403-404. [Extract] [Full Text] [PDF]

Data were misrepresented
Wendy S Biggs
BMJ 2008 336: 404. [Extract] [Full Text] [PDF]

Cardiovascular risks of calcium supplements in women
Graeme Jones and Tania Winzenberg
BMJ 2008 336: 226-227. [Extract] [Full Text] [PDF]

Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women
M C Chapuy, M E Arlot, P D Delmans, and P J Meunier
BMJ 1994 308: 1081-1082. [Full Text]

This article has been cited by other articles:

  • Majumdar, S. R (2008). Oral bisphosphonates and atrial fibrillation. BMJ 336: 784-785 [Full text]  
  • Andrews, N. A. (2008). Calcium Supplementation and Vascular Disease: A Legitimate New Worry?. IBMS BoneKEy 5: 124-129 [Full text]  
  • Lappe, J. M, Heaney, R. P (2008). Results may not be generalisable. BMJ 336: 403-403 [Full text]  
  • Biggs, W. S (2008). Data were misrepresented. BMJ 336: 404-404 [Full text]  
  • Ramlackhansingh, J. N (2008). Some issues on outcomes. BMJ 336: 403-403 [Full text]  
  • Puccetti, L. (2008). Confounders were ignored. BMJ 336: 403-404 [Full text]  
  • (2008). Cardiovascular Risk and Calcium Supplementation in Postmenopausal Women. JWatch General 2008: 1-1 [Full text]  
  • (2008). Calcium and Cardiovascular Risk: Connection Unclear. JWatch Women's Health 2008: 3-3 [Full text]  
  • Jones, G., Winzenberg, T. (2008). Cardiovascular risks of calcium supplements in women. BMJ 336: 226-227 [Full text]  
  • Winzenberg, T., Jones, G. (2008). Recommended Calcium Intakes in Children: Have We Set the Bar Too High?. IBMS BoneKEy 5: 59-68 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Primary end point undefined and confounders uncontrolled for
Luca Puccetti
bmj.com, 18 Jan 2008 [Full text]
Adjusting for current smoking status
Doina Kulick
bmj.com, 19 Jan 2008 [Full text]
Oxidative stress, vascular calcification and coronary events in advanced age
Katrin Aasvee
bmj.com, 20 Jan 2008 [Full text]
Misrepresentation of study data
Wendy S Biggs
bmj.com, 23 Jan 2008 [Full text]
The calcium hypothesis, once again
José Pedro L. Nunes
bmj.com, 25 Jan 2008 [Full text]
Invalid Result
Yasser K. Alotaibi
bmj.com, 30 Jan 2008 [Full text]
Some limitations in Bolland's study
Jian-Lie Zhou
bmj.com, 31 Jan 2008 [Full text]
Role of Magnesium in Calcium Metabolism
David P. Robinson
bmj.com, 1 Feb 2008 [Full text]
The need for vitamin K in calcium supplements
Leon J Schurgers, et al.
bmj.com, 1 Feb 2008 [Full text]
Vascular events and calcium supplementation
Joan M. Lappe, et al.
bmj.com, 4 Feb 2008 [Full text]
calcium is toxic to vessels
Jayendra Gohil
bmj.com, 5 Feb 2008 [Full text]
CONSORT statement forgotten by BMJ
Klaus H Witt, et al.
bmj.com, 5 Feb 2008 [Full text]
Omission of important vascular events
Phillip Moradi
bmj.com, 6 Feb 2008 [Full text]
Vitamin D
MJ Wilkinson
bmj.com, 6 Feb 2008 [Full text]
Calcium supplementaion and vascular events
Jinelle N. Ramlackhansingh
bmj.com, 6 Feb 2008 [Full text]
RE: Forgotten CONSORT
Amy L Davis, et al.
bmj.com, 7 Feb 2008 [Full text]
Questionable physical chemistry and statistics
Christopher Nordin, et al.
bmj.com, 8 Feb 2008 [Full text]
Bad science
Ivor Cammack
bmj.com, 11 Feb 2008 [Full text]
Response to Letters to BMJ re Bolland et al
Ian R Reid, et al.
bmj.com, 19 Feb 2008 [Full text]
Possible side effect of Calcium and/or Vitamin D supplements
Audrey Lorraine Aspeling
bmj.com, 4 May 2008 [Full text]



Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview